SLP
Simulations Plus Inc.
Halal Rating :
See Details
Last Price
$28.78
Last updated:
Market Cap
$546.23m
7D Change
-5.92%
1 Year Change
-26.17%
Company Overview
Industries
Exchange
Nasdaq
Next Earnings Date
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym; IPFsym; RENAsym; MITOsym.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Aug. 31, 2024 | $18.66m | $19.82m | - | - | 0.00% | 0.00% |
| May 31, 2024 | $18.54m | $16.66m | - | - | 0.00% | 0.00% |
| Feb. 29, 2024 | $18.3m | $13.86m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Simulations Plus Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.